Cargando…
Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy
Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of neurotoxic anticancer drugs that may affect quality of life (QoL). Purpose: The purposes of this study were to: assess the levels of CIPN, anxiety, depression, CIPN–related QoL, and general QoL; and identify the factors...
Autores principales: | Hung, Hsing-Wei, Liu, Chien-Ying, Chen, Hsiu-Fang, Chang, Chun-Chu, Chen, Shu-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199281/ https://www.ncbi.nlm.nih.gov/pubmed/34073174 http://dx.doi.org/10.3390/ijerph18115677 |
Ejemplares similares
-
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019) -
The Efficacy of Acupuncture in Chemotherapy-Induced Peripheral
Neuropathy: Systematic Review and Meta-Analysis
por: Chien, Tsai-Ju, et al.
Publicado: (2019) -
Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017) -
Recent advances in understanding chemotherapy-induced peripheral neuropathy
por: Gordon-Williams, Richard, et al.
Publicado: (2020) -
IMPACT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY ON THE QUALITY OF LIFE IN CANCER PATIENTS
por: Novak, Marica, et al.
Publicado: (2022)